Table 3:
Variable | Treatment effect* 12 weeks – baseline (95%CI) | p value, interaction term | |
---|---|---|---|
Initial hemoglobin level < 13.0 g/dL n = 49 |
Initial hemoglobin level ≥ 13.0 g/dL n = 149 |
||
Hemoglobin, g/dL | 0.97 (0.54 to 1.40) | 0.09 (−0.22 to 0.41) | < 0.001 |
Ferritin, μg/L | 8.4 (2.0 to 14.8) | 12.7 (7.5 to 17.9) | 0.4 |
Mean corpuscular volume, fL | 1.0 (−1.8 to 3.9) | 2.2 (0.9 to 3.5) | 0.4 |
Hematocrit, % | 2.3 (0.2 to 4.4) | 0.5 (−0.7 to 1.7) | 0.1 |
Transferrin, g/L | −0.1 (−0.4 to 0.2) | −0.2 (−0.4 to 0.03) | 0.5 |
Soluble transferrin receptor, mg/L | −0.89 (−1.6 to −0.2) | −0.4 (−0.6 to −0.1) | 0.05 |
Transferrin saturation, % | 2.5 (−5.7 to 10.7) | 3.8 (−1.7 to 9.2) | 0.8 |
Note: CI = confidence interval.
A hot-deck method with 10 imputations was used to account for data that were missing and lost to follow-up.